2 weeks Ago By ABMN Staff
Shares of Humana Inc. ( NYSE:HUM – Get Free Report ) have earned an average recommendation of “Hold” from the twenty-one research firms that are presently covering the company, Marketbeat Ratings reports. Twelve research analysts have rated the stock with a hold recommendation and nine have assigned a buy recommendation to the company.
The average twelve-month target price among analysts that have covered the stock in the last year is $398.70. A number of research analysts have issued reports on HUM shares.
TD Cowen upped their target price on shares of Humana from $396.00 to $407.00 and gave the company a “buy” rating in a research report on Wednesday, July 24th.
Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $395.00 price objective on shares of Humana in a research note on Friday, September 20th. Truist Financial upped their target price on shares of Humana from $355.
00 to $400.00 and gave the company a “hold” rating in a research report on Monday, July 15th. Morgan Stanley initiated coverage on Humana in a research note on Monday, June 24th.
They issued an “equal weight” rating and a $374.00 price target on the stock. Finally, Piper Sandler began coverage on Humana in a research note on Wednesday, June 26th.
They set an “overweight” rating and a $392.00 price objective for the company. View Our Latest Research Report on HUM Humana Trading Up 2.
1 % Humana ( NYSE:HUM – Get Free Report ) last posted its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share for the quarter, topping the consensus estimate of $5.
89 by $1.07. The firm had revenue of $29.
54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. Humana had a net margin of 1.
53% and a return on equity of 16.12%. Humana’s revenue was up 10.
4% on a year-over-year basis. During the same quarter in the previous year, the company posted $8.94 EPS.
As a group, equities analysts anticipate that Humana will post 16.01 earnings per share for the current fiscal year. Humana Dividend Announcement The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th.
Investors of record on Monday, September 30th will be paid a $0.885 dividend. This represents a $3.
54 dividend on an annualized basis and a yield of 1.11%. The ex-dividend date of this dividend is Monday, September 30th.
Humana’s payout ratio is presently 22.04%. Institutional Inflows and Outflows Hedge funds have recently modified their holdings of the company.
CarsonAllaria Wealth Management Ltd. grew its stake in shares of Humana by 111.4% during the 2nd quarter.
CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after acquiring an additional 39 shares in the last quarter. Hantz Financial Services Inc.
bought a new position in Humana in the second quarter valued at $35,000. Family Firm Inc. bought a new position in Humana in the second quarter valued at $37,000.
Carolinas Wealth Consulting LLC increased its stake in Humana by 274.1% in the 4th quarter. Carolinas Wealth Consulting LLC now owns 101 shares of the insurance provider’s stock valued at $46,000 after buying an additional 74 shares during the last quarter.
Finally, Hollencrest Capital Management bought a new stake in Humana during the 2nd quarter worth about $40,000. 92.38% of the stock is currently owned by institutional investors.
About Humana ( Get Free Report Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals.
It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. See Also Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter .
.
